Court extends ED custody of Gujarat-based pharma firm’s director to February 7
By PTI, January 29, 2018
Sterling Biotech director Rajbhushan Omprakash Dixit is to be confronted with various documents and co-accused to unearth the larger conspiracy in a money laundering case related to a ₹5,000 crore bank fraud case.
A Delhi court has extended till February 7 the Enforcement Directorate (ED) custody of a director of a Gujarat-based pharma firm in a money laundering case related to a ₹5,000 crore bank fraud case.
Additional Sessions Judge Sidharth Sharma extended the custody of Rajbhushan Omprakash Dixit, a director of Sterling Biotech, after Special Public Prosecutor Nitesh Rana, appearing for the ED, said his further custodial interrogation was required by the agency.
Mr. Rana told the court that the accused, arrested on January 25, is to be confronted with various documents and co-accused to unearth the larger conspiracy.
Third arrest
This is the third arrest in the case. The ED arrested Anup Prakash Garg, a former director of Andhra Bank, earlier this month, and Delhi-based businessman Gagan Dhawan in November 2017.
While Mr. Garg is currently in judicial custody, Mr. Dhawan was granted bail on January 4. All three were arrested under the Prevention of Money Laundering Act (PMLA).
They were named as accused in the cases by the ED and the CBI. The ED had registered a money laundering case after taking cognisance of a CBI FIR.
The CBI had booked Sterling Biotech, its directors, Mr. Rajbhushan, Chetan Jayantilal Sandesara, Dipti Chetan Sandesara, Nitin Jayantilal Sandesara and Vilas Joshi, chartered accountant Hemant Hathi, Mr. Garg and some unidentified persons in connection with the bank fraud case.
It had alleged that the company had taken loans of over ₹5,000 crore from a consortium led by Andhra Bank that had turned into non-performing assets.
The FIR also alleged that the total pending dues of the group companies were ₹5,383 crore as on December 31, 2016.
Comments
Post a Comment